Biostax Corp. (BTAX)
| Market Cap | 21.53K +24.7% |
| Revenue (ttm) | n/a |
| Net Income | -1.87M |
| EPS | -0.02 |
| Shares Out | 107.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 271 |
| Open | 0.0002 |
| Previous Close | 0.0001 |
| Day's Range | 0.0002 - 0.0002 |
| 52-Week Range | 0.0001 - 0.0002 |
| Beta | 0.74 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 29, 2026 |
About Biostax
Biostax Corp. operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products. Its lead investigational drug candidate Lodonal, an once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Its programs also include Global Telehealth platform; Medtech asset, an early development stage program that uses blockchain and smart contracts to manage and secure prescriptions and electronic health records; JKB-122,... [Read more]
Financial Performance
Financial StatementsNews
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company focused on developing innovative immune restoration therapies, ...
Biostax Corp. to Participate in U.S. Business Action to End HIV Annual Coalition Meeting and World AIDS Day Reception
Orlando, FL, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Biostax Corp ., (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, proudly announces its participation in the upcoming U.S. Busine...
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
Orlando, FL, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the appointment of Influential Business Leader Roger “Cr...
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
Orlando, FL, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX) (“Biostax”), a hub and spoke biotech development engine, announces the appointment of Ms. Clay Caperton to its Board of Dir...
Biostax Announces FINRA Approval for Name and Ticker Symbol Change, Signals Entry into Global Substance Abuse Commercial Markets and Pioneering HIV Treatment
ORLANDO, Fla., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BTAX), a leading public company specializing in healthcare solutions, today announced a milestone in its transformative rebrand...